Turkish Journal of Veterinary & Animal Sciences
Volume 27

Number 2

Article 12

1-1-2003

Expression Profiles of IGF-I, IGF-II, bFGF and TGF-b2 Growth
Factors during Chicken Embryonic Development
HAKAN KOCAMIŞ
JOHN KILLEFER

Follow this and additional works at: https://journals.tubitak.gov.tr/veterinary
Part of the Animal Sciences Commons, and the Veterinary Medicine Commons

Recommended Citation
KOCAMIŞ, HAKAN and KILLEFER, JOHN (2003) "Expression Profiles of IGF-I, IGF-II, bFGF and TGF-b2
Growth Factors during Chicken Embryonic Development," Turkish Journal of Veterinary & Animal
Sciences: Vol. 27: No. 2, Article 12. Available at: https://journals.tubitak.gov.tr/veterinary/vol27/iss2/12

This Article is brought to you for free and open access by TÜBİTAK Academic Journals. It has been accepted for
inclusion in Turkish Journal of Veterinary & Animal Sciences by an authorized editor of TÜBİTAK Academic
Journals. For more information, please contact academic.publications@tubitak.gov.tr.

Turk J Vet Anim Sci
27 (2003) 367-372
© TÜB‹TAK

Research Article

Expression Profiles of IGF-I, IGF-II, bFGF and TGF-β2 Growth
Factors during Chicken Embryonic Development
Hakan KOCAMIfi
Department of Histology-Embryology, Faculty of Veterinary Medicine, Kafkas University, 36100, Kars - TURKEY

John KILLEFER
Division of Animal and Veterinary Sciences, West Virginia University, Morgantown WV 26506, USA

Received: 05.10.2001

Abstract: Skeletal muscle development in avian embryos depends on the activation, proliferation, differentiation, and fusion of
embryonic myoblasts. These processes as well as early embryonic development are mainly regulated by major growth factors such
as IGF-I, IGF-II, TGF-β and FGFs. In order to determine their differential expression, total RNA was isolated from whole embryos
on each of the embryonal days (E) 0 to 6, from the thoracic/abdominal half of the embryo at E 7 and E 8, and from pectoralis
muscle tissues at E 9 to E 20. Growth factor cDNAs were synthesized by reverse-transcription polymerase chain reaction (RT-PCR).
All growth factor messages except TGF-β2 were first detected as early as the blastula stage. IGF-I mRNA levels gradually declined
on E 1 and remained lower through E 10. Levels then dramatically increased on E 11 (~ 3.5-fold) and remained high through E 13.
On the other hand, overall the amount of IGF-II mRNA fluctuated from E 0 to E 20. Levels between E 0 and E 5 remained high and
then declined (~ 3-fold) through E 16. TGF-β2 mRNA first appeared on E 3 and then levels remained high with slight fluctuations
until E 18. bFGF mRNA levels increased (~ 2.5-fold) on E 3 and remained high with slight fluctuations until E 13. Because of the
correlation of gene expression with the timing of major myogenic events, we suggest that IGF-I, bFGF and TGF-β2 are major
regulators of embryonic skeletal muscle development in chickens.
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Tavuk Embriyolar›n›n Geliflim Sürecinde, IGF-I, IGF-II, bFGF, ve TGF-β2
Büyüme Faktörlerinin Expresyon Profili
Özet: Kanatl› embriyolar›ndaki çizgili kas geliflimi embriyonal myoblastlar›n aktivasyonu, ço¤almas›, farkl›laflmas›, ve füzyonuna
ba¤l›d›r. IGF-I, IGF-II, TGF-β ve FGF gibi büyüme faktörleri bu proseslerle birlikte daha erken olan embriyo geliflimini düzenler. Bu
büyüme faktörlerinin ayr› ayr› expresyonunu belirlemek için, ilk 6 günde (E O ile E 6 aras›) embriyonun tamam›ndan, 7. ve 8. günde
(E 7 ve E 8) gö¤üs ve kar›n k›sm›ndan, 9-20. günlerde ise (E 9 ile E 20 aras›) sadece gö¤üs kaslar›ndan RNA’lar elde edildi. Daha
sonra, büyüme faktörlerine ait cDNA’lar, Reverse-Transcription Polymerase Chain Reaction (RT-PCR) tekni¤i kullan›larak sentez
edildi. TGF-β2 haricindeki bütün büyüme faktörlerinin gen expresyonu en erken blastula aflamas›nda saptand›. IGF-I mRNA miktar›
embriyonun birinci gününden itibaren azald› ve 10’uncu güne kadar düflük seviyede kald›. Di¤er taraftan, genel IGF-II mRNA miktar›
embriyonun 20’nci gününe kadar iniflli ç›k›flli seyretti. fiöyleki, 16'nc› embriyonik güne kadar 1-5'nci günler aras›ndaki seviyenin
yaklafl›k olarak 1/3’üne geriledi. TGF-β2 mRNA ilk olarak embriyonun 3’üncü gününde gözlendi ve miktar› küçük inifl ç›k›fllarla
beraber embriyonun 18’inci gününe kadar yüksek kald›. bFGF mRNA miktar› ise 3’üncü gününde artt› ve embriyonun 13’üncü
gününe kadar küçük inifl ç›k›fllarla birlikte yüksek seyretti. Bu araflt›rmada gen expresyonu ile kas geliflimini düzenleyen
mekanizmalar›n zamanlamas› aras›ndaki uyuma paralel olarak, IGF-I, bFGF, TGF-β2’nin tavuklar›n embriyonik çizgili kas gelifliminde
önemli bir düzenleyici olabilecegi sonucuna var›ld›.
Anahtar Sözcükler: IGF-I, IGF-II, bFGF, TGF-β2, Tavuk Embriyosu

Introduction
Although the effects of growth factors on cultured
cells have been extensively studied, relatively little is
known of their actual roles in embryos. One of the
important steps in elucidating the functions of growth
factors in embryos is the investigation of their expression
pattern and relationship with developmental processes.
Skeletal muscle is derived from somites migrating from

the paraxial mesoderm into the adjacent region of the
embryo (1). In chickens, myogenic cells start migrating
from somites at approximately 2.5 days of incubation.
The main myogenic period is spread over 10 days,
beginning in the middle third of the embryonic period (2).
Insulin-like growth factors, IGF-I and –II, are the
major requirements for the growth and development of
chick embryos. They have been shown to stimulate
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proliferation, differentiation and protein accretion of cells
derived from avian embryos (3,4). Because of the
absence of type-II IGF receptors, IGF-I and IGF-II have,
unlike in mammals, similar activities in chicken embryos
(4).
The transforming growth factor-β (TGF-β) family
contains a large number of structurally related
polypeptide growth factors that play a prominent role in
the development and homeostasis of virtually all tissues in
organisms. TGF-β1/β3 isoforms have been shown to be
present in gastrulating chicken embryo and have
functional effects on cell transformation, extracellular
matrix deposition and cell proliferation (5).
Among the several extracellular factors that regulate
myoblast proliferation and differentiation, the fibroblast
growth factor (FGF) family plays a major role in skeletal
muscle development. FGFs are required for the migration
of muscle precursor cells in early chick embryonic
development (6). The addition of FGFs has been shown to
both delay the onset of myogenesis and stimulate
proliferation of cultured mouse (7) and chicken (8) cells.
Thus, the objective of the current study was to establish
the ontogeny of IGF-I, IGF-II, TGF-β2 and bFGF gene
expression with regard to embryonic and chicken skeletal
muscle development.

Materials and Methods
Tissue collection
Fertilized eggs (Cobb X Cobb) were obtained from
Wampler-Longacre (Moorefield, WV). Embryos and
tissues were harvested in compliance with an approved
West Virginia University Animal Care and Use Committee
Protocol. All the embryos were isolated and washed free
of yolk, albumen and extra-embryonic membranes by
sterile nuclease-free water and were staged according to
Hamburger and Hamilton (9). Whole embryos were
collected on each of the embryonic days (E) 0 to 6 (stage
1 to stage 29, n = 6 per day). Thoracic/abdominal halves
of the embryos between the lumbo-sacral level and the
neck without the head were collected on each of E 7 and
E 8 (stage 31 and stage 34, respectively, n = 6 per day).
Pectoralis muscle was collected on each of E 9 to E 20 (n
= 4 per day). All the tissue collections were performed at
consistent times for each sampling day throughout the
experimental period, starting on day 9, stage 35, and
every 24 h until day 20, stage 45 (9).
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RNA extraction
Total RNA was extracted from all of the tissues
mentioned above using the Tri-Reagent (Sigma)
modification of the guanidine isothiocyanate/phenolchloroform method as described by Chomczynski and
Sacci (10). The RNA concentration was estimated by
absorbance at 260 nm in a Shimadzu spectrophotometer
(Columbia, MD). Samples of RNA were stored at -80 ºC.
RT-PCR
Reverse transcription (RT) was performed by adding
2 µg of total RNA to 2 µg of Oligo dT primers and
sterilized nuclease-free dd H2O in a final volume of 15 µl.
The samples were heated at 70 ºC for 5 min and then
immediately cooled to 4 ºC over 2 min. RT buffer
containing dNTPs (the final concentration of each was 10
mM), 25 units of RNase inhibitor, and 200 units of
murine maloney leukemia virus reverse transcriptase
(Promega, Madison, WI) were added to each sample. The
sample, with a final volume of 40 µl, was incubated at 37
ºC for 1 h followed by a 5 min incubation at 95 ºC. For
the PCR reaction, 2 µl of RT reaction mixture was added
to 48 µl of solution containing 5 µl of Taq buffer, 1 µl of
Taq DNA polymerase (Display Systems Biotech, Vista,
CA), 1 µl of dNTPs (final concentration of each was 10
mM), 1 µl each of forward and reverse primers and 41 µl
of sterile nuclease-free dd H2O. The PCR reaction started
with one cycle consisting of 94 ºC for 5 min, followed by
an annealing step of 65 ºC (for bFGF) or 55 ºC (for IGFI and β-actin) for 1 min and extension at 72 ºC for 1 min.
The first cycle was followed by 30 cycles consisting of 30s intervals of 94 ºC, followed by 65 ºC for bFGF or 55 ºC
for IGF-I and β-actin, followed by 72 ºC. For IGF-II and
TGF-β2, touchdown PCR was run. This program
consisted of a 5 min, 94 °C denaturation step, followed
by 5 cycles in which the initial annealing temperature of
72 °C for IGF-II and 65 °C for TGF-β2 was reduced by 1
°C per cycle, and then 30 cycles in which the annealing
temperatures were 68 °C for IGF-II and 61 °C for TGFβ2. Denaturation, extention and annealing time were
programmed as described above. A water (no cDNA) PCR
reaction was used as a control for each gene and no
contamination of reaction mixture components was
found.
PCR primers
All PCR primers were obtained from Gibco BRL Inc.
(Grand Island, NY). Primers for bFGF and TGF-β2 were
designed on the basis of published sequences of chicken
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bFGF and TGF-β2 (11,12). Primers for bFGF amplified a
PCR product of 270 bp, which corresponded to bases
432-701 of the sequence, while primers for TGF-β2
amplified a PCR product of 269 bp, which corresponded
to bases 6452-6722 of the sequence. The sequences of
forward primers for bFGF and TGF-β2 were 5’
GATCCGCACATCAAACTGC 3’,

stained gels, and data should therefore be considered on
a semi-quantitative basis. The identity of all PCR products
was confirmed by sequence analysis.

5’ AGGAATGTGCAGGATAATT 3’, while the reverse
primers were

β-Actin (house-keeping gene) was used for
normalization of gene expression data and appeared to be
consistently expressed throughout chicken embryonic
development (Fig. 1).

5’
GATACGTTTCTGTCCAGGTCC
3’,
5’
ATTTTGGGTGTTTTGCCAA 3’, respectively. Primers for
IGF-I and IGF-II were designed on the basis of published
sequences of chicken IGF-I and IGF-II (13,14). The
sequences of forward primers for IGF-I and IGF-II were
5’
GTATGTGGAGACAGAGGCTTC
3’,
5’
TGTGGAGGAGTGCTGCTTTC 3’, while the reverse
primers were 5’ TTTGGCATATCAGTGTGGCGC 3’,
5’ GGGAGGTGGCGGAGAGGTCA 3’, respectively. Forward
and reverse primers amplified a PCR product of 200 bp
for IGF-I, which corresponded to bases of 439-638,
while primers for IGF-II amplified a 101 bp PCR product,
which corresponded to bases of 44-145. Primers for βactin were used to amplify a 285 bp product as previously
published (15), as an internal standard for normalizing
the level of amplification. The sequence of the forward
primer was
5' TCATGAAGTGTGACGTTGACATCCGT 3', while the reverse
primer was 5' CCTAGAAGCATTTGCGGTGCACGATG 3'.
The amplified PCR products for each gene were
visualized on 1.5% agarose gels, stained with ethidium
bromide. Products were analyzed by densitometry of

Results
β-Actin mRNA levels

IGF-I and IGF-II mRNA Levels
Expression of IGF-I and IGF-II genes were first seen
during the blastoderm stage of chick embryo
development. IGF-I mRNA levels gradually declined on E
1 and remained lower through E 10 (Fig. 2A). Levels then
dramatically increased on E 11 (~ 3.5-fold) and remained
high through E 13. IGF-I mRNA declined at E 14 (~ 2fold) and plateaued through E 18. Levels then decreased
prior to hatching. The highest and lowest IGF-I mRNA
levels were seen in 11- and 6-day-old chick embryos,
respectively. Overall the amount of IGF-II mRNA
fluctuated from E 0 to E 20 (Fig. 2B). Levels between E
0 and E 5 remained high and then declined (~ 3-fold)
through E 16. The highest and lowest IGF-II mRNA levels
were seen in 3- and 15-day-old chick embryos,
respectively.
TGF-β2 and bFGF mRNA Levels
TGF-β2 gene expression was first seen in 3-day-old
chick embryos (Fig. 3A). The amount of TGF-β2 mRNAs
remained high with slight fluctuations until E 18. Levels
then declined prior to hatching (~ 4-fold). bFGF gene

Figure 1.
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Figure 2.
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Steady-state levels of IGF-I (A) and
IGF-II (B) mRNA in whole embryo,
thoracic/abdominal half and
skeletal muscle during chick
embryo development (n = 6 or 4
per day, respectively). The bands
for IGF-I and IGF-II on the
photograph were scanned by
densitometer and the integration
values (mean ± SD), after
normalization to β-actin, are
expressed
in
arbitrary
densitometric units at each day.
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expression was first seen during the blastoderm stage of
chick embryo development (Fig. 3B). The amount of
bFGF mRNA remained low until E 8 with a sudden
increase at E 3. Levels then increased (~ 2.5-fold) and
plateaued until E 13. The highest and lowest bFGF mRNA
levels were seen in 2- and 11-day-old chick embryos.

Studies have shown that primary muscle formation
occurs by E 7 and secondary muscle fiber formation
occurs between E 7 and E 18 in chicken embryos (1618). Approximately 80% of myofiber number is
completed between E 7 and E 18 (major myoblast fusion
starts at E 11).

were not able to detect IGF-I mRNA expression before E
3 by a nuclease protection assay as opposed to our
findings of strong expression in the E 0 (blastoderm
stage). Actions of IGF-II on vertebrata development,
particularly in skeletal muscle growth, have not been fully
established yet (20). For instance, post-natal growth of
IGF-II null mice was similar to that of normal control mice
(18), whereas transgenic mice overexpressing IGF-II
grew more slowly than did control animals (21). The
autocrine expression of IGF-II correlated with the rate of
spontaneous differentiation of various muscle cell lines
(22). In this respect, our findings of low IGF-II gene
expression during mid-embryogenesis when most of the
muscle fiber formation occurs were in disagreement with
those in vitro findings.

Our results demonstrating that IGF-I mRNA
accumulated to a peak level during mid-embryogenesis
and then declined prior to hatching were in agreement
with those of Kikuchi et al. (19). However, these authors

The bioactivity of IGFs is modulated by IGF-binding
proteins (IGFBPs) found in the extracellular fluids and
serum of mammals. Even though mammals have six
distinct classes of IGFBP, termed IGFBP-1 through

Discussion
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Figure 3.
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Steady-state levels of TGF-β2 (A)
and bFGF (B) mRNA in whole
embryo, thoracic/abdominal half
and skeletal muscle during chick
embryo development (n = 6 or 4
per day, respectively). The bands
for TGF-β2 and bFGF on the
photograph were scanned by
densitometer and the integration
values (mean ± SD), after
normalization to β-actin, are
expressed
in
arbitrary
densitometric units at each day.
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IGFBP-6, only IGFBP-2 (23) and IGFBP-5 (24) have been
isolated from chickens. Therefore, to facilitate a better
understanding of the regulatory roles of IGFs, it is
important to establish the developmental expression
pattern of these binding proteins in whole embryo and
skeletal muscle tissues as well.
Sanders et al. (5) demonstrated that TGF-β1/β3
isoforms were expressed in gastrulating chick embryos
and had functional effects on cell transformation,
extracellular matrix deposition and cell proliferation.
However, in the present study, TGF-β2 expression was
not detected during early embryonic development. TGFβ2 mRNA levels increased in C2C12 myoblast cell cultures
when the cells were allowed to differentiate in low-serum
medium (25). Our results in which TGF-β2 mRNA

expression increased during mid-embryogenesis when the
majority of muscle differentiation takes place were in
agreement with those in vitro findings. FGF is highly
mitogenic for many muscle cell types and is also a potent
inhibitor of myogenic differentiation in these cells (26).
Additionally, Moore et al. (27) reported that FGFs and
their receptor mRNAs in myoblast cell cultures were
down-regulated during differentiation. However, in the
current study, bFGF mRNA expressions were upregulated during muscle differentiation (E 9 to E 18).
A complete understanding of the functions of growth
factors and the activation of their gene expression in
developing chicken embryos could be beneficial in food
animal agriculture.
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